DWK Life Sciences acquires Müller + Müller
Müller + Müller will be managed by CEO Florian Müller-Stauch
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
M&A
Bristol Myers Squibb to acquire Forbius
Forbius’s lead TGF-beta asset, AVID200, is an isoform-selective TGF-beta inhibitor, currently in Phase 1 for oncology and fibrosis
Sanofi to acquire Principia Biopharma
The deal adds to Sanofi’s R&D areas of autoimmune and allergic diseases
Advent International to acquire controlling stake in RA Chem Pharma from Micro Labs
The transaction is Advent’s sixth investment in the healthcare sector and seventh investment in India over the past twelve months
Sun Pharma arm to acquire Aquinox Pharmaceuticals (Canada)
The cost of acquisition is about $8.2 million
KKR to acquire controlling stake in JB Chemicals and Pharmaceuticals
KKR will make the investment through its subsidiaries, Tau Investments Holdings, Tau Holdco, and KKR Asia III Fund Investments
Piramal Pharma to acquire manufacturing facility from G&W Laboratories in the US
Located in Sellersville, Pennsylvania, this facility will broaden the offering of Piramal Pharma Solutions (PPS) by adding solid…
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS,…
Cipla acquires stake in GoApptiv
The acquisition of 21.85 per cent stake on a fully diluted basis will be completed in two stages
Boehringer Ingelheim acquires Northern Biologics’ preclinical cancer antibody pipeline
The acquisition provides assets targeting tumour stroma and myeloid cells